The Recovery of Platelet Malondialdehyde Production After a Single Intake of Aspirin - The Effect of Dosage

Summary

We studied the recovery pattern of platelet malondialdehyde (MDA) formation after a single intake of various doses of aspirin (ASA). In normal subjects, there were striking differences in the recovery pattern between large doses (1,000 or 500 mg) and small doses (100 or 50 mg) of oral ASA. The 2 day lag phase was present in the large dose group which showed the complete inhibition of the circulating platelets 2 hr after oral ASA but not in the small dose group which showed the incomplete inhibition. The difference of recovery time between these two groups was about 2 days. These data suggest that ASA’s effect on megakaryocytes might affect the recovery pattern of MDA formation by the circulating platelets. In 2 patients with chronic idiopathic thrombocytopenic purpura, the 2 day lag phase was not observed in the recovery even after a large ASA dose.

Keywords

Platelet life span - Aspirin - Malondialdehyde - Thiobarbituric acid reaction - Megakaryocyte

• References

• 1 Stuart MJ, Murphy S, Oski FA. A simple non radioisotope technic for the determination of platelet life-span. N Engl J Med 1975; 292: 1310-1313
• 2 Catalano PM, Smith JB, Murphy S. Platelet recovery from aspirin inhibition in vivo; Differing patterns under various assay conditions. Blood 1981; 57: 99-105
• 3 Mustard JF. Platelet survival. Thromb Haemostas 1978; 40: 154-162
• 4 Kocsis JJ, Hernandovich J, Silver MJ, Smith JB, Ingerman C. Duration of inhibition of platelet prostaglandin formation and aggregation by ingested aspirin or indomethacin. Prostaglandins 1973; 3: 141-144
• 5 Burch JW, Stanford N, Majerus PW. Inhibition of platelet prostaglandin synthetase by oral aspirin. J Clin Invest 1978; 61: 314-319
• 6 Jafari E, Saleem A, Shaikh BS, Demers LM. Effect of aspirin on prostaglandin synthesis by human platelets. Prostaglandins 1976; 12: 829-835
• 7 Szczeklik A, Gryglewski RJ, Grodzinska L, Musial J, Serwonska M, Marcinkiewicz E. Platelet aggregability, thromboxane A₂ and malonaldehyde formation following administration of aspirin to man. Thromb Res 1979; 15: 405-413
• 8 Ali M, McDonald JWD, Thiessen JJ, Coates PE. Plasma acetylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin. Stroke 1980; 11: 9-13
• 9 Demers LM, Budin RE, Shaikh BS. The effects of aspirin on megakaryocyte prostaglandin production. Proc Soc Exp Biol Med 1980; 163: 24-29
• 10 Dejena E, Barbieri B, Cerletti C, Livio M, de Gaetano G. Impaired thromboxane production by newly formed platelets after aspirin administration to thrombocytopenic rats. Br J Haematol 1980; 46: 465-469
• 11 Worthington RE, Nakeff A. The aspirin effect in rat megakaryocytes and its implication for megakaryocyte differentiation. Blood 1981; 58 (Suppl. 01) 119a
• 12 Yoshimoto T, Yamamoto S, Okuma M, Hayaishi O. Solubilization and resolution of thromboxane synthesizing system from microsomes of bovine blood platelets. J Biol Chem 1977; 252: 5871-5874
• 13 Okuma M, Steiner M, Baldini M. Studies on lipid peroxides in platelets. I. Method of assay and effect of storage. J Lab Clin Med 1970; 75: 283-296
• 14 Takayama H, Okuma M, Uchino H. A simple method for estimation of lipoxygenase and cyclo-oxygenase pathways in human platelets - the use of thiobarbituric acid reaction. Thromb Haemostas 1980; 44: 111-114
• 15 Okuma M, Uchino H. Altered arachidonate metabolism by platelets in patients with myeloproliferative disorders. Blood 1979; 54: 1258-1271
• 16 Silver MJ, Smith JB, Ingerman C, Kocsis JJ. Arachidonic acid-induced platelet aggregation and prostaglandin formation. Prostaglandins 1973; 4: 863-875
• 17 Placer ZA, Cushman LL, Johnson BC. Estimation of product of lipid peroxidation (Malonyl Dialdehyde) in biochemical systems. Anal Biochem 1966; 16: 359-364
• 18 Peng GW, Gadalla MAF, Smith V, Peng A, Chiou WL. Simple and rapid high-pressure liquid chromatographic simultaneous determination of aspirin, salicylic acid, and salicyluric acid in plasma. J Pharm Sci 1978; 67: 710-712
• 19 de Haas HA, Clark SE, Zahavi J, Kakkar VV, White AM. A modified non-radioisotope method for measurement of platelet production time. Br J Haematol 1979; 43: 137-141
• 20 Pryor WA, Stanley JP. A suggested mechanism for the production of malondialdehyde during the autoxidation of polyunsaturated fatty acids. Non-enzymatic production of prostaglandin endoperoxides during autoxidation. J Org Chem 1975; 40: 3615
• 21 White HL, Glassman AT. Biochemical properties of the prostaglandin/thromboxane synthetase of human blood platelets and comparison with the synthetase of bovine seminal vesicles. Prostaglandins 1976; 12: 811-828
• 22 Branehög I, Kutti J, Ridell B, Swalin B, Weinfeld A. The relation of thrombokinetics to bone marrow megakaryocytes in idiopathic thrombocytopenic purpura (ITP). Blood 1975; 45: 551-562
• 23 Karpatkin S. Autoimmune thrombocytopenic purpura. Blood 1980; 56: 329-343
• 24 Hamberg M, Svensson J, Blombäck M, Mettinger KL. Shortened megakaryocyte-platelet regeneration time in patients with ischemic cerebrovascular disease. Thromb Res 1981; 21: 675-679